Headlines med Postere til årets ASCO i juni ligger nå ute på nett, og denne ser jo interessant ut)
Study to evaluate intraperitoneal (IP) ONCOS-102 with systemic durvalumab in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Phase 2 results.
Presenter: Dmitriy Zamarin, MD, PhD | Memorial Sloan Kettering Cancer Center
Abstract: 2600
| Poster: Online Only
https://meetings.asco.org/meetings/2022-asco-annual-meeting/288/program-guide/posters